Citation: U. Heemann et al., NONINVASIVE MONITORING OF GRAFT DYSFUNCTION AFTER RENAL-TRANSPLANTATION, Infusionstherapie und Transfusionsmedizin, 25(1), 1998, pp. 25-29
Authors:
WITZKE O
WINTERHAGEN T
REINHARDT W
HEEMANN U
GROSSEWILDE H
KREUZFELDER E
ROGGENDORF M
PHILIPP T
Citation: O. Witzke et al., COMPARISON BETWEEN SUBCUTANEOUS AND INTRAVENOUS INTERLEUKIN-2 TREATMENT IN HIV DISEASE, Journal of internal medicine, 244(3), 1998, pp. 235-240
Authors:
FERNANDEZ ED
ALBRECHT KH
HEEMANN U
KOHNLE M
ERHARD J
STOBLEN F
EIGLER FW
Citation: Ed. Fernandez et al., PREVALENCE OF DIVERTICULOSIS AND INCIDENCE OF BOWEL PERFORATION AFTERKIDNEY-TRANSPLANTATION IN PATIENTS WITH POLYCYSTIC KIDNEY-DISEASE, Transplant international, 11(1), 1998, pp. 28-31
Authors:
SZABO A
SALLAY P
KRIBBEN A
ROSS S
ROGGENDORF M
TULASSAY T
PHILLIPP T
HEEMANN U
Citation: A. Szabo et al., HEPATITIS-G VIRUS-INFECTION IN CHILDREN ON DIALYSIS AND AFTER RENAL-TRANSPLANTATION, Pediatric nephrology, 12(2), 1998, pp. 93-95
Authors:
WITZKE O
BECKER G
ERHARD J
LUTKES P
SZABO A
PHILIPP T
HEEMANN U
Citation: O. Witzke et al., TACROLIMUS RESCUE THERAPY IN PATIENTS WITH REJECTION AND LONG-TERM DIALYSIS AFTER KIDNEY-TRANSPLANTATION, Clinical nephrology, 49(1), 1998, pp. 24-27
Authors:
KOHNLE M
LUTKES P
WITZKE O
PHILIPP T
HEEMANN U
Citation: M. Kohnle et al., CONVERSION TO TACROLIMUS IN CYCLOSPORINE-A TREATED PATIENTS WITH GUM HYPERPLASIA, Transplantation proceedings, 30(5), 1998, pp. 2122-2123
Authors:
SPILLNER J
KOHNLE M
ALBRECHT KH
HEEMANN U
Citation: J. Spillner et al., ANTI-LFA-1 MONOCLONAL-ANTIBODY IN RENAL-TRANSPLANTATION - RENAL-FUNCTION, INFECTIONS, AND OTHER COMPLICATIONS, Transplantation proceedings, 30(5), 1998, pp. 2163-2163
Authors:
MULLER V
HAMAR P
SZABO A
KNUST E
VOGELSANG M
HEEMANN U
Citation: V. Muller et al., EFFECT OF MYCOPHENOLATE MOFETIL ON THE IN-VIVO INFILTRATION OF LYMPHOCYTES IN THE RAT REMNANT KIDNEY, Transplantation proceedings, 30(4), 1998, pp. 982-982
Authors:
MULLER V
BECKER G
DELFS M
ALBRECHT KH
PHILIPP T
HEEMANN U
Citation: V. Muller et al., DO URINARY-TRACT INFECTIONS TRIGGER CHRONIC KIDNEY-TRANSPLANT REJECTION IN MAN, The Journal of urology, 159(6), 1998, pp. 1826-1829
Authors:
HEEMANN U
HAMAR P
SZABO A
MULLER V
WITZKE O
SCHADE U
PHILIPP T
Citation: U. Heemann et al., IL-2 DEPENDENT MECHANISMS ARE INVOLVED IN CHRONIC KIDNEY ALLOGRAFT-REJECTION IN RATS, Journal of the American Society of Nephrology, 8, 1997, pp. 3066-3066
Citation: Mc. Michel et al., COMPARISON OF OLD AND NEW IMX-ASSAYS FOR MONITORING OF TACROLIMUS LEVELS, Transplant international, 10(5), 1997, pp. 409-410
Authors:
BECKER G
WITZKE O
FRIEDRICH J
ALBRECHT KH
WAGNER K
PHILIPP T
HEEMANN U
Citation: G. Becker et al., RESCUE THERAPY WITH TACROLIMUS IN SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION/, Transplant international, 10(1), 1997, pp. 51-54
Authors:
SCHMIDT S
CHUDEK J
KARKOSZKA H
HEEMANN U
REICHEL H
RAMBAUSEK M
KOKOT F
RITZ E
Citation: S. Schmidt et al., THE BSMI VITAMIN-D-RECEPTOR POLYMORPHISM AND SECONDARY HYPERPARATHYROIDISM, Nephrology, dialysis, transplantation, 12(8), 1997, pp. 1771-1772
Authors:
SZABO A
VIAZOV S
HEEMANN U
KRIBBEN A
PHILIPP T
ROGGENDORF M
Citation: A. Szabo et al., GBV-C HGV INFECTION IN RENAL DIALYSIS AND TRANSPLANT PATIENTS/, Nephrology, dialysis, transplantation, 12(11), 1997, pp. 2380-2384
Authors:
PATSCHAN O
KUTTLER B
HEEMANN U
UBER A
RETTIG R
Citation: O. Patschan et al., KIDNEYS FROM NORMOTENSIVE DONORS LOWER BLOOD-PRESSURE IN YOUNG TRANSPLANTED SPONTANEOUSLY HYPERTENSIVE RATS, American journal of physiology. Regulatory, integrative and comparative physiology, 42(1), 1997, pp. 175-180
Authors:
WITZKE O
PLENTZ A
SCHAFERS RF
REINHARDT W
HEEMANN U
PHILIPP T
Citation: O. Witzke et al., SIDE-EFFECTS OF RITONAVIR AND ITS COMBINATION WITH SAQUINAVIR WITH SPECIAL REGARD TO RENAL-FUNCTION, AIDS, 11(6), 1997, pp. 836-838
Authors:
RISCH K
BECKER G
GRASER E
NIZZE H
BROCK J
VOLK HD
HEEMANN U
LEHMANN M
Citation: K. Risch et al., INHIBITION OF CHRONIC REJECTION AFTER KIDNEY-TRANSPLANTATION BY ANTI-CD4 TREATMENT, Transplantation proceedings, 29(1-2), 1997, pp. 328-329
Authors:
MAYER AD
DMITREWSKI J
SQUIFFLET JP
BESSE T
GRABENSEE B
KLEIN B
EIGLER FW
HEEMANN U
PICHLMAYR R
BEHREND M
VANRENTERGHEM Y
DONCK J
VANHOOFF J
CHRISTIAANS M
MORALES JM
ANDRES A
JOHNSON RWG
SHORT C
BUCHHOLZ B
REHMERT N
LAND W
SCHLEIBNER S
FORSYTHE JLR
TALBOT D
NEUMAYER HH
HAUSER I
ERICZON BG
BRATTSTROM C
CLAESSON K
MUHLBACHER F
POHANKA E
Citation: Ad. Mayer et al., MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL-ALLOGRAFT REJECTION - A REPORT OF THEEUROPEAN TACROLIMUS-MULTICENTER-RENAL-STUDY-GROUP, Transplantation, 64(3), 1997, pp. 436-443
Citation: C. Schmid et al., FACTORS CONTRIBUTING TO THE DEVELOPMENT OF CHRONIC REJECTION IN HETEROTOPIC RAT-HEART TRANSPLANTATION, Transplantation, 64(2), 1997, pp. 222-228
Authors:
WITZKE O
HEEMANN U
THESING A
WOLFHARD U
ERHARD J
PHILIPP T
MICHEL MC
Citation: O. Witzke et al., A COMPARISON OF EMIT AND FPIA METHODS FOR THE DETECTION OF CYCLOSPORINE-A BLOOD-LEVELS - DOES IMPAIRED LIVER-FUNCTION MAKE A DIFFERENCE, European Journal of Clinical Pharmacology, 52(5), 1997, pp. 413-416
Citation: T. Philipp et U. Heemann, NEW DEVELOPMENTS IN IMMUNOSUPPRESSIVE DRUGS IN THE FIELD OF RENAL-TRANSPLANTATION - FOREWORD, Clinical nephrology, 45(5), 1996, pp. 325-325
Citation: K. Wagner et al., EXPERIMENTAL AND CLINICAL-EXPERIENCE WITH THE USE OF TACROLIMUS (FK506) IN KIDNEY-TRANSPLANTATION, Clinical nephrology, 45(5), 1996, pp. 332-335